BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33595705)

  • 1. Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
    Inokuchi S; Itoh S; Yoshizumi T; Morinaga A; Toshima T; Takeishi K; Nagao Y; Harada N; Ikegami T; Shimokawa M; Mori M
    Langenbecks Arch Surg; 2021 May; 406(3):773-779. PubMed ID: 33595705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection.
    Lin ZX; Ruan DY; Li Y; Wu DH; Ma XK; Chen J; Chen ZH; Li X; Wang TT; Lin Q; Wen JY; Wu XY
    World J Gastroenterol; 2015 Oct; 21(38):10898-906. PubMed ID: 26478681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
    Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
    Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Value of the Modified Systemic Inflammation Score in Patients With Extranodal Natural Killer/T-Cell Lymphoma.
    Huang H; Chen LM; Fang XJ; Guo CC; Lin XP; Hong HM; Li X; Wang Z; Tian Y; Chen MT; Yao YY; Chen Z; Li XQ; Pan F
    Front Pharmacol; 2020; 11():593392. PubMed ID: 33101044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection.
    Itoh S; Yugawa K; Shimokawa M; Yoshiya S; Mano Y; Takeishi K; Toshima T; Maehara Y; Mori M; Yoshizumi T
    BJS Open; 2019 Aug; 3(4):500-508. PubMed ID: 31388642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of systemic inflammation score in patients with hepatocellular carcinoma after hepatectomy.
    Shi S; Chen Q; Ye L; Yin D; Li X; Dai Z; He J
    Oncotarget; 2017 Oct; 8(45):79366-79375. PubMed ID: 29108315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modified Systemic Inflammation Score Is an Independent Predictor of Long-Term Outcome in Patients Undergoing Surgery for Adenocarcinoma of the Esophagogastric Junction.
    Xiong J; Kang W; Ma F; Liu H; Ma S; Li Y; Jin P; Hu H; Tian Y
    Front Surg; 2021; 8():622821. PubMed ID: 34820414
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correlation between postoperative neutrophil to lymphocyte ratio and recurrence and prognosis of hepatocellular carcinoma after radical liver resection].
    Wu XL; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):365-371. PubMed ID: 29860764
    [No Abstract]   [Full Text] [Related]  

  • 10. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma.
    Fu X; Li T; Dai Y; Li J
    BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accurate Prediction of Prognosis After Radical Resection of Gastric Cancer by the Modified Systemic Inflammation Score; a Multicenter Dataset Analysis.
    Inagaki K; Kanda M; Nakanishi K; Ito S; Mochizuki Y; Teramoto H; Ishigure K; Murai T; Asada T; Ishiyama A; Matsushita H; Tanaka C; Kobayashi D; Fujiwara M; Murotani K; Kodera Y
    World J Surg; 2021 Aug; 45(8):2513-2520. PubMed ID: 33934199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
    Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
    J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
    Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
    Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of the Preoperative Systemic Inflammation Score in Patients With Pancreatic Ductal Adenocarcinoma.
    Iguchi T; Iseda N; Hirose K; Itoh S; Harada N; Ninomiya M; Sugimachi K; Honboh T; Maeda T; Sadanaga N; Matsuura H
    Am Surg; 2023 Jun; 89(6):2213-2219. PubMed ID: 35392670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
    Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
    Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.
    Jin J; Zhu P; Liao Y; Li J; Liao W; He S
    Oncotarget; 2015 Aug; 6(22):19217-27. PubMed ID: 26057470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified Systemic Inflammation Score is Useful for Risk Stratification After Radical Resection of Squamous Cell Carcinoma of the Esophagus.
    Kanda M; Koike M; Tanaka C; Kobayashi D; Hattori N; Hayashi M; Yamada S; Omae K; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2019 Dec; 26(13):4773-4781. PubMed ID: 31605344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
    Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
    J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
    Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
    Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and validation of the prognostic value of preoperative systemic immune cells in hepatocellular carcinoma after curative hepatectomy.
    Liao R; Peng C; Li M; Li DW; Jiang N; Li PZ; Ding X; Wu Q; Du CY; Gong JP
    Cancer Med; 2018 Apr; 7(4):1170-1182. PubMed ID: 29533004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.